Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cancer Survivor × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 3 Uterine Cervical Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Condylomata Acuminata 1 Cancer Survivor 1

Interventions

Vaccines, Synthetic 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01492582 2021-10-27

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

University of Alabama at Birmingham

Phase 2 Completed

1,499 enrolled 11 charts

Cancer Survivor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡